The Fenofibrate And Microvascular Event Eye (FAME 1 EYE) Trial: A Randomised Trial in Adults With Type 1 Diabetes Mellitus Evaluating the Effects of Daily Oral Fenofibrate Compared With Placebo on Macular Thickness and Volume.
Not yet recruiting
Phase of Trial: Phase III
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Fenofibrate (Primary)
- Indications Diabetic macular oedema; Diabetic retinopathy
- Focus Biomarker; Therapeutic Use
- Acronyms FAME-1-EYE
- 26 Jul 2012 Additional lead trial investigators added as reported by ClinicalTrials.gov.
- 28 Mar 2011 New trial record